Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 4/2015

01-08-2015 | Case Report

Acute infection by hepatitis E virus with a slight immunoglobulin M antibody response

Authors: Yuki Inagaki, Yukio Oshiro, Mamiko Imanishi, Kazunori Ishige, Masaharu Takahashi, Hiroaki Okamoto, Nobuhiro Ohkohchi

Published in: Clinical Journal of Gastroenterology | Issue 4/2015

Login to get access

Abstract

The anti-hepatitis E virus (HEV) immunoglobulin (Ig) M antibody response is generally regarded as a useful marker for diagnosing primary infection. However, in some cases, this antibody is not detected during the acute phase of infection. An 81-year-old man with stable membranous nephropathy who presented with asymptomatic acute liver dysfunction came to our hospital. HEV RNA of genotype 3 was detected in his serum, and he was diagnosed with acute hepatitis E. According to an enzyme-linked immunosorbent assay, high-level positivity for anti-HEV IgG and IgA antibodies was observed, but the assay was negative for IgM antibody throughout the clinical course of infection. The patient was not immunosuppressed. We further investigated the presence of IgM antibody using two other polyclonal antibodies against human IgM as secondary antibodies and another recombinant ORF2 protein of genotype 3 as an immobilized antigen. IgM was weakly detected in the serum during the acute phase only by the test with the antigen of genotype 3. Multi-genotype antigens can detect a slight IgM antibody response; however, anti-HEV IgA is more useful in diagnosing primary HEV infection, particularly in cases with a low IgM antibody response.
Literature
1.
go back to reference Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol. 2008;48:494–503.CrossRefPubMed Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol. 2008;48:494–503.CrossRefPubMed
3.
go back to reference Mizuo H, Yazaki Y, Sugawara K, et al. Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan. J Med Virol. 2005;76:341–9.CrossRefPubMed Mizuo H, Yazaki Y, Sugawara K, et al. Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan. J Med Virol. 2005;76:341–9.CrossRefPubMed
4.
go back to reference Mitsui T, Tsukamoto Y, Hirose A, et al. Distinct changing profiles of hepatitis A and E virus infection among patients with acute hepatitis, patients on maintenance hemodialysis and healthy individuals in Japan. J Med Virol. 2006;78:1015–24.CrossRefPubMed Mitsui T, Tsukamoto Y, Hirose A, et al. Distinct changing profiles of hepatitis A and E virus infection among patients with acute hepatitis, patients on maintenance hemodialysis and healthy individuals in Japan. J Med Virol. 2006;78:1015–24.CrossRefPubMed
5.
go back to reference Takahashi M, Okamoto H. Features of hepatitis E virus infection in humans and animals in Japan. Hepatol Res. 2014;44:43–58.CrossRefPubMed Takahashi M, Okamoto H. Features of hepatitis E virus infection in humans and animals in Japan. Hepatol Res. 2014;44:43–58.CrossRefPubMed
7.
go back to reference Mitsui T, Tsukamoto Y, Suzuki S, et al. Serological and molecular studies on subclinical hepatitis E virus infection using periodic serum samples obtained from healthy individuals. J Med Virol. 2005;76:526–33.CrossRefPubMed Mitsui T, Tsukamoto Y, Suzuki S, et al. Serological and molecular studies on subclinical hepatitis E virus infection using periodic serum samples obtained from healthy individuals. J Med Virol. 2005;76:526–33.CrossRefPubMed
8.
go back to reference Takikawa Y, Miyamoto Y, Onodera M, et al. Icteric acute hepatitis E with no response of immunoglobulin M class anti-hepatitis E virus antibody. Hepatol Res. 2012;42:1146–9.CrossRefPubMed Takikawa Y, Miyamoto Y, Onodera M, et al. Icteric acute hepatitis E with no response of immunoglobulin M class anti-hepatitis E virus antibody. Hepatol Res. 2012;42:1146–9.CrossRefPubMed
9.
go back to reference Okamoto H, Mishiro S, Tokita H, et al. Superinfection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/2a or I/1a. Hepatology. 1994;20:1131–6.CrossRefPubMed Okamoto H, Mishiro S, Tokita H, et al. Superinfection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/2a or I/1a. Hepatology. 1994;20:1131–6.CrossRefPubMed
10.
go back to reference Takikawa H, Onji M. A proposal of the diagnostic scale of drug induced liver injury. Hepatol Res. 2005;32:250–1.CrossRefPubMed Takikawa H, Onji M. A proposal of the diagnostic scale of drug induced liver injury. Hepatol Res. 2005;32:250–1.CrossRefPubMed
11.
go back to reference Mizuo H, Suzuki K, Takikawa Y, et al. Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan. J Clin Microbiol. 2002;40:3209–18.PubMedCentralCrossRefPubMed Mizuo H, Suzuki K, Takikawa Y, et al. Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan. J Clin Microbiol. 2002;40:3209–18.PubMedCentralCrossRefPubMed
12.
go back to reference Takahashi M, Kusakai S, Mizuo H, et al. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) is highly specific for diagnosis of acute HEV infection. J Clin Microbiol. 2005;43:49–56.PubMedCentralCrossRefPubMed Takahashi M, Kusakai S, Mizuo H, et al. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) is highly specific for diagnosis of acute HEV infection. J Clin Microbiol. 2005;43:49–56.PubMedCentralCrossRefPubMed
13.
go back to reference Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol. 2006;16:5–36.CrossRefPubMed Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol. 2006;16:5–36.CrossRefPubMed
14.
go back to reference Takahashi M, Hoshino Y, Tanaka T, et al. Production of monoclonal antibodies against hepatitis E virus capsid protein and evaluation of their neutralizing activity in a cell culture system. Arch Virol. 2008;153:657–66.CrossRefPubMed Takahashi M, Hoshino Y, Tanaka T, et al. Production of monoclonal antibodies against hepatitis E virus capsid protein and evaluation of their neutralizing activity in a cell culture system. Arch Virol. 2008;153:657–66.CrossRefPubMed
15.
go back to reference Matsubayashi K, Kang JH, Sakata H, et al. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion. 2008;48:1368–75.CrossRefPubMed Matsubayashi K, Kang JH, Sakata H, et al. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion. 2008;48:1368–75.CrossRefPubMed
16.
go back to reference Mitsui T, Tsukamoto Y, Yamazaki C, et al. Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion. J Med Virol. 2004;74:563–72.CrossRefPubMed Mitsui T, Tsukamoto Y, Yamazaki C, et al. Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion. J Med Virol. 2004;74:563–72.CrossRefPubMed
17.
go back to reference Seriwatana J, Shrestha MP, Scott RM, et al. Clinical and epidemiological relevance of quantitating hepatitis E virus-specific immunoglobulin M. Clin Diagn Lab Immunol. 2002;9:1072–8.PubMedCentralPubMed Seriwatana J, Shrestha MP, Scott RM, et al. Clinical and epidemiological relevance of quantitating hepatitis E virus-specific immunoglobulin M. Clin Diagn Lab Immunol. 2002;9:1072–8.PubMedCentralPubMed
18.
go back to reference Bendall R, Ellis V, Ijaz S, et al. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J Med Virol. 2008;80:95–101.CrossRefPubMed Bendall R, Ellis V, Ijaz S, et al. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J Med Virol. 2008;80:95–101.CrossRefPubMed
Metadata
Title
Acute infection by hepatitis E virus with a slight immunoglobulin M antibody response
Authors
Yuki Inagaki
Yukio Oshiro
Mamiko Imanishi
Kazunori Ishige
Masaharu Takahashi
Hiroaki Okamoto
Nobuhiro Ohkohchi
Publication date
01-08-2015
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 4/2015
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-015-0589-4

Other articles of this Issue 4/2015

Clinical Journal of Gastroenterology 4/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.